4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0001193125-26-345836
Chief Commercial Officer acquired 62,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Wiley Matthew T. · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-12 | Grant or award : show line 1 in the form | +62,500 | 237,133 | D |
Loading xslF345X06/ownership.xml…